Ricopili drug
Evidence from:
primary |
all sources
Related entities (2)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Ricopili | associated_with | PGC | — | 1 |
| Ricopili | associated_with | Psychiatric Genomics Consortium | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
- Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| ricopili | drug | 2 | 2 |
| rapid imputation for consortias pipeline | drug | — | — |